Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among those on Wegovy than among those on Ozempic.

Kim Wohlwend with Midwest Mind and Body Healthcare said the pill version of Wegovy is not just beneficial for patients who are scared of needles."Somebody who travels a lot should maybe look more at ...

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not reporting potential side effects of the drugs.

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug ...

A new battle between these longtime rival companies will likely go the same way as their previous battles.

By Stine Jacobsen and Maggie Fick COPENHAGEN, March 9 (Reuters) - Novo Nordisk said on Monday it will sell its blockbuster Wegovy and Ozempic drugs through the U.S. telehealth company Hims & Hers ...

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

Novo Nordisk announced up to 50% price cuts for Ozempic and Wegovy diabetes and weight-loss drugs starting January 2027, ...

The price of the company's popular GLP-1 drugs could come down by as much as 50% next year.

Kim Wohlwend with Midwest Mind and Body Healthcare said the pill version of Wegovy is not just beneficial for patients who ...